Commercialization: Page 72
-
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski CONTRIBUTING EDITORS Virginia Kirk Denise Myshko Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2002 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Two, Numb...
By Taren Grom • Jan. 13, 2010 -
The Value of Innovation
BY ALEX ROBINSON Let’s stop complaining about spending on prescription drugs,” Alan Holmer, president of the Phar maceutical Research and Manufacturers of Ameri ca (PhRMA) told an audience in April. “In fact, let’s hope that prescription drug spending goes up — not down.” Critics are quick to poi...
By Alex Robinson • Jan. 11, 2010 -
Talent Pool
Pharma POOL Margaret M.FORAN Chuck HARDWICK Pat KELLY Ian READ Pfizer Names Presidents for U.S., European Pharmaceuticals Businesses,Head of Corporate Affairs, and Corporate Secretary Pat Kelly and Ian Read have been appointed presidents responsible for the U.S. and European pharmaceuticals busin...
By PharmaVoice Team • Jan. 11, 2010 -
E-Media
NEW ELECTRONIC AND WEB BASED APPLICATIONS, SITES, AND TECHNOLOGIES MDchoice.com Inc. has unveiled a new marketing platform that allows hospitals, clinics, and physician groups to offer their own private label online healthcare information services. The platform offers health information ranging f...
By PharmaVoice Team • Jan. 11, 2010 -
What's New
NEW HEALTHCARE RELATED PRODUCTS, SERVICES, AND COMPANIES Dorland Sweeney Jones Health Communications is reaffirming its position as a leader in global health communications and creating a power brand by simplifying its name and organizational structure. The agency has returned to its original nam...
By PharmaVoice Team • Jan. 11, 2010 -
PharmaTrax
Teams and effective practices that drive corporate growth. “Successful new product plan ning efforts realize that analytical teamstaffing efforts are essential to today’s blockbuster products,” says Paul Meade, VP at Best Prac tices. “Teams that have well rounded members who can bring a combinati...
By PharmaVoice Team • Jan. 11, 2010 -
Incentive Compensation
As the new environment of pharma sales shifts to more specialized and consumer-centric approaches, the industry will need to respond to adequately compensate and incentivize its sales teams. Our experts say prescription numbers will remain the predominant measurement for sales rep performance in...
By Robin Robinson • Dec. 29, 2009 -
Contents
In Every Issue 3 Letter from the Editor 8 Upfront A brief review of industry news at press time 36 Pharma Trax Sales, marketing, and R&D trends from industry analysts 40 What’s New New healthcare-related products, services, and companies 42 E-Media New electronic and Web-based applications, s...
By PharmaVoice Team • Dec. 28, 2009 -
Pharmaceutical Manufacturing Under Scrutiny
Across the board — from labeling and marketing, to clinical trials, to manufacturing processes — regulators are becoming more active in safeguarding the public and ensuring the safety of pharmaceuticals. Even before the news broke regarding Genzyme Corp.’s recent virus and contamination problems ...
By PharmaVoice Team • Dec. 28, 2009 -
Name That Brand: A Pilot Program
The eventual outcome of the FDA’s two-year Proprietary Name Review pilot project may have positive implications for the industry in the long run, but in the short term, it means more money spent and more time pressure for marketers. Our experts say the burden on pharma companies to conduct their ...
By Robin Robinson • Dec. 28, 2009 -
Last Word
taking stock of the media After the two-day hearing, do you believe FDA officials have a better understanding of social media and what the industry is trying to achieve? Gratton: I think we are at the beginning of the process. Does the FDA understand all of the nuances of the digital landscape —...
By PharmaVoice Team • Dec. 28, 2009 -
Talent Pool
Biotechnology POOL Dr. Diane JORKASKY Aileron Therapeutics Appoints Medical Chief Aileron Therapeutics, a biotechnology company discovering and developing a novel class of therapeutics called stapled peptides, has appointed Diane Jorkasky, M.D., senior VP, head of development and chief medical of...
By PharmaVoice Team • Dec. 28, 2009 -
What's New
Oncology Performance Edge, Health Strategies Group’s recently launched strategic research service, helps marketing and sales executives in the oncology field improve brand performance by understanding how best to invest their resources. “The oncology market is significantly different from others,...
By PharmaVoice Team • Dec. 28, 2009 -
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Most Americans Want More Info on New Biotechnologies Sidebars: What Do You Think Synthetic Biology Is? Rating the Best Drivers of Attendance to speaker events Pharma Rebranding of Speaker Events Is Paying Off Japan Prese...
By PharmaVoice Team • Dec. 28, 2009 -
UpFront
Honors and Awards GCPj Bestows Honors The Global Clinical Practices Journal (GCPj) recognized several companies in 2009 for providing excellence in the clinical trials industry: • Chiltern’s Katie Huffine, BSN, MSN, won Project Manager of the Year. • Cognizant and AstraZeneca won the Clinical ...
By PharmaVoice Team • Dec. 28, 2009 -
Letter from the Editor
Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing EDitor Denise Myshko Senior EDitor Robin Robinson features EDitor Kim Ribbink Contributing Editor Carolyn Gretton design associate Ariel Medel national account manager Cathy Tracy CIRCULATION Assistant Kathy Deiuliis C...
By PharmaVoice Team • Dec. 28, 2009 -
The Year Ahead
Looking back to the varying changes and pressures the industry has endured, and ahead to how the industry will need to reinvent itself to continue to prosper, companies are adapting to longer-term marketplace trends and evolving patient needs. The industry is facing pressure from the economic, re...
By Denise Myshko and Robin Robinson • Nov. 10, 2009 -
Online Media: Will it Kill the Mass Media Stars?
Jeff Baker is President and CEO, Noble Marketing Group, a provider of PhRMA-compliant creative marketing solutions for pharmaceutical, biotechnology, and healthcare providers. For more information, visit gonoblerx.com. “There will be more focus on education versus branding, and because of the g...
By Robin Robinson • Nov. 10, 2009 -
Social Media
Arecent Manhattan Research report states that 88% of all physicians use the Internet to access pharmaceutical, biotech, and medical device information, and 41% of all the research that physicians conduct is now done online. Nielsen’s online data show that about half of the U.S. population visited...
By Robin Robinson • Nov. 10, 2009 -
The Salesforce of the Future
Our experts agree: the salesforce of the future will be more specialized, more technically advanced, and more clinically savvy; oh, and there will be fewer feet on the street, finally. If the past year is any indication, the salesforce of the future is going to experience an extreme makeover. For...
By PharmaVoice Team • Nov. 10, 2009 -
The Innovation Challenge
There has been a great deal of discussion related to the challenges hampering innovation to create differentiated medicines. Never before have research and cutting-edge science been more important to ensure a steady flow of innovation. Much has been made of the industry’s decline in R&D pro...
By PharmaVoice Team • Nov. 10, 2009 -
Reform, Consolidation, and Good Citizenry
Reform, Consolidation, and Good Citizenry Our experts featured in this issue identify healthcare reform, mergers and acquisitions, and corporate reputation as three of the many market changers that will impact how the industry does business in the future. Healthcare Reform: What’s to Come? The ye...
By Robin Robinson • Nov. 10, 2009 -
The Crystal Ball
We asked our readers to identify the top trends and market shapers they expect to define the various industry sectors in the coming year. Some of their responses may already be on your radar, while others may provide a new and different perspective. There’s little doubt that 2010 will be another...
By PharmaVoice Team • Nov. 10, 2009 -
On the Calendar
November 16-17 Pharmaceutical Coverage & Reimbursement Conference Washington, D.C. Q1 Productions, q1productions.com November 16-17 The 3rd Pediatric Clinical Trials Grand Hyatt Washington, Washington, D.C. ExL Pharma, exlpharma.com November 17-18, 2009 13th Advanced Forum on Structuring, Neg...
By PharmaVoice Team • Nov. 9, 2009 -
Index
Julian Adams, Ph.D. President, Research and Development and Chief Scientific Officer, Infinity Pharmaceuticals Inc. Brent Ahrens. General Partner, Canaan Partners Kenneth C. Aldrich. CEO, Chairman, and Co-Founder, International Stem Cell Corp. Meryl Allison. Principal, Deloitte Consulting Karl...
By PharmaVoice Team • Nov. 9, 2009